News

Current vaccines to prevent COVID-19 are highly effective in producing antibodies in pregnant people, resulting in more antibodies than what is generated from a natural SARS-CoV-2 virus infection, according to a study funded by the National Institutes of Health. Moreover, antibodies produced after vaccination are present in breastmilk and travel across the placenta, indicating that vaccination during pregnancy will also confer immunity to newborns.

For many COVID-19 patients, full recovery remains elusive even long after they should feel “better.” NIH recently announced research opportunities to understand COVID-19 long haulers, who have what researchers now refer to as Post-acute sequelae of SARS-CoV-2 infection (PASC). NICHD joins these opportunities while remaining focused on PASC patients within our audiences of interest—pregnant and lactating people, children, and those with disabilities.

A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who have been prescribed the drug to treat COVID-19. The study, which will be conducted at 17 sites in the continental United States and Puerto Rico, aims to determine how pregnant women metabolize the drug and whether there are any potential side effects.

Pregnant people need to be protected through research rather than from research, the authors contend.

As the COVID-19 pandemic persists, SARS-CoV-2 vaccines offer the potential to halt the spread of the virus. Yet, we know very little about the effectiveness and safety of the vaccines during pregnancy.

NIH-funded study suggests mother-to-infant transmission appears to be rare

Increased stress may interfere with adjustment to new motherhood, mother-infant bonding

Read about NICHD’s research findings and activities from 2020.

Vegetarian diets during pregnancy are associated with small infant birth weight, but not a higher risk preterm birth or other medical complications, suggests a National Institutes of Health study.

Environmental, biological samples span the period from preconception to early childhood.

Human milk oligosaccharides found in breastmilk may influence a child’s growth from infancy through early childhood, according to an NICHD-supported study.

The longer a woman with gestational, or pregnancy-related, diabetes breastfeeds her infant, the lower her risk for developing type 2 diabetes later in life, suggests an analysis by researchers at the National Institutes of Health and other institutions.

To expand the reach of its crowdsourcing pregnancy research project, the National Institutes of Health (NIH) recently launched a Spanish version of PregSource®.

Women who breastfed their infants exclusively for 7 to 12 months may have a significantly lower risk of early menopause than their peers who breastfed their infants for less than a month, according to an analysis funded by the National Institutes of Health.

A study from federal researchers shows that information about ways to reduce the risk of sleep-related infant deaths is not reaching all caregivers or healthcare providers.

NIH-supported research calls for well-defined standards for infants between 6 months and 1 year

Infants of the extinct human species Australopithecus africanus likely breast fed for up to a year after birth, similar to modern humans but of shorter duration than modern day great apes, according to an analysis of fossil teeth funded in part by the National Institutes of Health. The findings provide insight into how breast feeding evolved among humans and may inform strategies to improve modern breast-feeding practices.

NICHD was established more than 50 years ago to help understand maternal health and improve pregnancy outcomes. These selected advances highlight NICHD’s contributions to advancing the health and well-being of pregnant women, mothers, and families everywhere.

Group seeks to enhance testing of therapeutics used by pregnant women and nursing mothers.